Biosensor Analysis of Drug–Target Interactions: Direct and Competitive Binding Assays for Investigation of Interactions between Thrombin and Thrombin Inhibitors

By Karlsson R.   Kullman-Magnusson M.   Hämäläinen M.D.   Remaeus A.   Andersson K.   Borg P.   Gyzander E.   deinum J.  

Analytical Biochemistry, Vol. 278, Iss. 1, 2000-02 ,pp. : 1-13

Elsevier

Access to resources Recommend Favorite

Oligonucleotide Inhibitors of Human Thrombin that Bind Distinct Epitopes

By Tasset D.M.   Kubik M.F.   Steiner W.  

Journal of Molecular Biology, Vol. 272, Iss. 5, 1997-10 ,pp. : 688-698

Academic Press

Access to resources Recommend Favorite

Use of Stopped-Flow Spectrophotometry to Establish Midpoint Potentials for Redox Proteins

By Sørlie M.   Seefeldt L.C.   Parker V.D.  

Analytical Biochemistry, Vol. 287, Iss. 1, 2000-12 ,pp. : 118-125

Elsevier

Access to resources Recommend Favorite

Expression and Purification of the Human Thrombin Receptor

By Chinni C.   Bottomley S.P.   Duffy E.J.   Hemmings B.A.   Stone S.R.  

Protein Expression and Purification, Vol. 13, Iss. 1, 1998-06 ,pp. : 9-15

Academic Press

Access to resources Recommend Favorite

Volume 278, Number 1 (2000), in the article “Biosensor Analysis of Drug–Target Interactions: Direct and Competitive Binding Assays for Investigation of Interactions between Thrombin and Thrombin Inhibitors,” by Robert Karlsson, Mari Kullman-Magnusson, Markku D. Hämäläinen, Annika Remaeus, Karl Andersson, Peter Borg, Erika Gyzander, and Johanna Deinum, pages 1–13 (doi:10.1006/abio.1999.4406)

By  

Analytical Biochemistry, Vol. 291, Iss. 2, 2001-04 ,pp. : 306-306

Elsevier

Access to resources Recommend Favorite